Holmes Biopharma, Inc. (LMB) Misses Q1 EPS by 65c, Slight Beat on Revenues; Boosts FY19 Revenue Outlook
Go back to Holmes Biopharma, Inc. (LMB) Misses Q1 EPS by 65c, Slight Beat on Revenues; Boosts FY19 Revenue Outlook| Holmes Biopharma, Inc. (NASDAQ: LMB) | Delayed: 48.81 -0.73 (1.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.54 | 52 Week High | $0.15 | |||
| Open | $48.80 | 52 Week Low | $0.15 | |||
| Day High | $49.72 | P/E | N/A | |||
| Day Low | $47.02 | EPS | $0.00 | |||
| Volume | 460,056 | |||||
